BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23530819)

  • 1. Mortalin - a multipotent chaperone regulating cellular processes ranging from viral infection to neurodegeneration.
    Flachbartová Z; Kovacech B
    Acta Virol; 2013; 57(1):3-15. PubMed ID: 23530819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy.
    Shankaranarayana AH; Meduri B; Pujar GV; Hariharapura RC; Sethu AK; Singh M; Bidye D
    Future Med Chem; 2023 Nov; 15(22):2087-2112. PubMed ID: 37877348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortalin (HSPA9) facilitates
    Wu PK; Hong SK; Chen W; Becker AE; Gundry RL; Lin CW; Shao H; Gestwicki JE; Park JI
    Sci Signal; 2020 Mar; 13(622):. PubMed ID: 32156782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
    Starenki D; Hong SK; Lloyd RV; Park JI
    Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial HSP70 Chaperone System-The Influence of Post-Translational Modifications and Involvement in Human Diseases.
    Havalová H; Ondrovičová G; Keresztesová B; Bauer JA; Pevala V; Kutejová E; Kunová N
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells.
    Starenki D; Sosonkina N; Hong SK; Lloyd RV; Park JI
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability.
    Wu PK; Hong SK; Starenki D; Oshima K; Shao H; Gestwicki JE; Tsai S; Park JI
    Oncogene; 2020 May; 39(21):4257-4270. PubMed ID: 32291414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.
    Wadhwa R; Ryu J; Ahn HM; Saxena N; Chaudhary A; Yun CO; Kaul SC
    J Biol Chem; 2015 Mar; 290(13):8447-56. PubMed ID: 25645922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.
    Shelton MN; Huang MB; Ali SA; Powell MD; Bond VC
    J Virol; 2012 Jan; 86(1):406-19. PubMed ID: 22013042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?
    Wadhwa R; Taira K; Kaul SC
    Cell Stress Chaperones; 2002 Jul; 7(3):309-16. PubMed ID: 12482206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From proliferative to neurological role of an hsp70 stress chaperone, mortalin.
    Deocaris CC; Kaul SC; Wadhwa R
    Biogerontology; 2008 Dec; 9(6):391-403. PubMed ID: 18770009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of nuclear mortalin in human carcinogenesis.
    Ryu J; Kaul Z; Yoon AR; Liu Y; Yaguchi T; Na Y; Ahn HM; Gao R; Choi IK; Yun CO; Kaul SC; Wadhwa R
    J Biol Chem; 2014 Sep; 289(36):24832-44. PubMed ID: 25012652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
    Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N
    Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Druggability of mortalin for cancer and neuro-degenerative disorders.
    Deocaris CC; Lu WJ; Kaul SC; Wadhwa R
    Curr Pharm Des; 2013; 19(3):418-29. PubMed ID: 22920904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-sulfur cluster assembly.
    Shan Y; Cortopassi G
    Mitochondrion; 2016 Jan; 26():94-103. PubMed ID: 26702583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.
    Wadhwa R; Takano S; Kaur K; Deocaris CC; Pereira-Smith OM; Reddel RR; Kaul SC
    Int J Cancer; 2006 Jun; 118(12):2973-80. PubMed ID: 16425258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone.
    Amick J; Schlanger SE; Wachnowsky C; Moseng MA; Emerson CC; Dare M; Luo WI; Ithychanda SS; Nix JC; Cowan JA; Page RC; Misra S
    Protein Sci; 2014 Jun; 23(6):833-42. PubMed ID: 24687350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Ao K; Yin M; Lyu X; Xiao Y; Chen X; Zhong S; Wen X; Yuan J; Ye M; Zhang J; Li X; Hao Y; Guo X
    Cancer Lett; 2024 Apr; 587():216658. PubMed ID: 38253218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of mortalin in cellular senescence from the perspective of its mitochondrial import, chaperone, and oxidative stress management functions.
    Yaguchi T; Aida S; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2007 Apr; 1100():306-11. PubMed ID: 17460192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.